PP-003

N/A

Report date: 2024/03/01 11:56:41
NMEFirst In Class

Base Information

Drug NamePP-003
Drug Alias NamePP-003
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSynuclein alpha degraders
TargetsSynuclein alpha
Therapy Area/IndicationsParkinson Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanada
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesPrimary Peptides Inc
China Registration ClassN/A

Develop Information

Active CompaniesPrimary Peptides Inc
Inactive CompaniesN/A
Active IndicationsParkinson Disease
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A